`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`ACRUX DDS PTY LTD., ACR{JX LIMITED, and
`ARGENT{?JM PHARMACEUTICALS LLC,
`Petitioners
`
`l'
`
`V.
`
`KAKEN PHARMACEUTICAL co., LTD. and
`VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
`Patent Owners.
`
`Case: IPR2017-00190
`U.S. Pate'nt No. 7,214,506
`
`ACRUX'S REVOCATION OF POWER OF ATTORNEY AND
`NEW POWER OF ATTORNEY PURSUANT TO 37 C.F.R. § 42.10(b)
`
`Petitioners Acrux DDS Pty Ltd. and Acrux Limited ("Acrux") hereby revoke
`
`all previous Powers of Attorney granted in connection with the above-identified
`
`petition for Inter Partes Review and hereby appoint the following practitioners as
`
`its attorneys to transact all business in the United States Patent & Trademark
`
`Office associated with the Petition for Inter Partes Review of U.S. Patent No.
`
`7,214,506 on behalf of Acrux:
`
`
`
`Lead Counsel
`Tara M. Raghavan (Reg. No. 55,557) -
`traghavan@rrnmslegal.com
`Postal and Hand Delive Address
`RAKOCZY MOLINO MAZZOCHI SIWIK
`LLP
`6 West Hubbard Street, Suite 500
`Chicago, Illinois 60654
`Tel: (312) 222-6340
`Fax: (312) 222-6341
`
`Back-up Counsel
`Steven J. Birkos (Reg. No. 65,300)
`sbirkos@rmmslegal.com
`William A. Rakoczy
`(pro hac vice.to be filed)'
`wrakoczy@rmmslegal.com
`Joseph T. Jaros
`(pro hac vice to be filed)
`jjaros@rrmnslegal.com
`Postal and Hand Delive Address
`RAKOCZY MOLINO MAZZOCHI SIWIK
`LLP
`6 West Hubbard Street, Suite 500
`Chicago, Illinois 60654
`Tel: (312) 222-5127
`Fax: (312) 222-6321
`
`The individuals signing below have the, authority to execute this document
`
`on behalf of Petitioners.
`
`ACRUX DDS PTY LTD.
`
`B)7:
`
`% Th
`
`'J
`
`Name:
`
`Nina Webster PhD, M.IP.Law, MBA
`
`Title :
`
`Commercial Director
`
`Date:
`
`' " 'August 2018
`
`22
`
`ACRUX LIMITED
`
`B7:
`
`/i')
`
`, o!:'/',<Z,?-
`
`Name :
`
`Michael Kotsanis
`
`Title:
`
`Date:
`
`CEO and Managing Director
`'I:" August 2018
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a true and correct copy of ACRUX'S
`
`REVOCATION OF POWER OF ATTORNEY AND NEW POWER OF
`
`ATTORNEY PURSUANT TO 37 C.F.R. § 42.10(b) was served on August 28,
`
`2018, via electronic mail by agreement of the parties, on the following:
`
`John D. Livingstone
`Finnegan, Henderson, Farabow, Garret & Dunner, L.L.P.
`271 17th Street, NW, Suite 1400
`Atlanta, GA 30363-6209
`john.livingstone@finnegan.com
`KakenIPR@finnegan.com
`
`Naoki Yoshida
`naoki.yoshida@finnegan.com
`Anthony Hartman
`anthony.hartman@finnegan.com
`Barbara R. Rudolph, Ph.D.
`barbara.rudolph@finnegan.com
`Finnegan, Henderson, Farabow, Garret & Dunner, L.L.P.
`901 New York Ave., NW
`Washington, DC 20001-4413
`
`Toan P. Vo
`toan.vo@bausch.com
`Valeant Pharmaceuticals North America LLC
`1400 N. Goodman Street
`Rochester, New York 14609
`
`Teresa Staneck Rea
`TRea@Crowell.com
`Shannon M. Lentz
`SLentz@Crowell.com
`Crowell & Moring LLP
`Intellectual Property Group
`1001 Pennsylvania Ave, NW
`
`
`
`
`
`
`
`Washington, DC 2004-2595
`
`Tyler C. Liu
`TLiu@agpharm.com
`Argentum Pharmaceuticals, LLC
`
`
`
`
`Dated: August 28, 2018
`
`
`
`By:
`
`
`
`
`Respectfully submitted,
`
`/Aydin H. Harston/
`E. Anthony Figg, Reg. No. 27,195
`Aydin H. Harston, Reg. No. 65,249
`ROTHWELL, FIGG, ERNST & MANBECK, P.C.
`607 14th St., N.W., Suite 800
`Washington, DC 20005
`Phone: 202-783-6040
`Fax: 202-783-6031
`
`
`
`